Could a simple stool test revolutionize TB diagnosis for kids and HIV patients?
NCT ID NCT05047315
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study evaluated a new stool-based test (qPCR) to diagnose tuberculosis (TB) in children under 8 and people living with HIV. Researchers in Mozambique, Eswatini, and Uganda tested nearly 2,000 participants to see if the stool test could improve TB detection rates compared to standard methods like sputum tests. The goal is to make TB diagnosis easier and more accessible for those who are often missed.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- stool-based qPCR diagnostic test
- What this could lead to
- If successful, this could provide a simpler, non-invasive way to diagnose tuberculosis in hard-to-test groups like children and people with HIV, potentially increasing detection rates.
- What could go wrong
- This is a completed diagnostic accuracy study, not a treatment trial. The test may not be accurate enough in real-world settings, and it does not directly improve health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
1,967 people
The number who actually took part.
- Started
-
Dec 2021
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Our proposed diagnostic evaluation will be performed in three high TB/HIV burden settings in populations where the tests are intended to be used (presumptive adult pulmonary TB cases and presumptive intrathoracic pediatric TB cases). The study will enroll presumptive TB cases within two study groups: 1. Children less than 8 years of age (irrespective of HIV status) 2. Adults living with HIV (\>15 years of age), irrespective of immunological status.
- Ages
-
0 to 8 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Pediatric Cohort * \<8 years of age * Identified with suspected PTB defined as follows: 1. A child with ≥1 of the following criteria: <!-- --> 1. Persistent unremitting cough (or cough significantly worse than usual in child with chronic lung disease including HIV-related) of \>2 weeks duration, unresponsive to a course of appropriate antibiotics (when clinically indicated) 2. Poor growth documented over the preceding 3 months \[clear deviation from a previous growth trajectory and/or documented crossing of centile lines in the preceding 3 months and/or; weight-for-age, or weight-for-height Z-score of ≤2 in the absence of information on previous/recent growth trajectory AND not responding to nutritional rehabilitation (or to antiretroviral therapy if HIV-infected)\] 3. Persistent unexplained lethargy or reduced playfulness/activity reported by the caregiver. 4. Persistent (\>1w) unexplained fever (\>38C), reported by a guardian or objectively recorded at least once; 5. In infants 0-60 days, also: unresponsive neonatal pneumonia or unexplained hepatosplenomegaly OR sepsis-like illness (all other more common causes excluded and/or not responding to appropriate therapy/ broad-spectrum antibiotics/antivirals). OR 2\) Any duration of cough/ wheeze/ acute pneumonia with ≥1: 1. TB exposure. Either: i) Documented/Reported exposure to a known TB source case (regardless of smear status) in previous 12months OR ii) immunological evidence: positive IGRA or positive TST (defined as \>5mm in HIV infected or severely malnourished, \>10 otherwise) 2. Chest radiograph suggestive of TB. Adult Cohort (WHO definition of a HIV-positive presumptive TB case) * \> 15 years of age * Confirmed HIV infection (ELISA or molecular) * Presenting at any health facility with any of the following: cough, fever, night sweats or unintentional weight loss (any duration). Exclusion criteria Participants will be excluded (both from study groups) if: * Receiving TB treatment for \>72 hours in previous 2 weeks * History of TB treatment in the last year * Refusal to provide consent for study participation or HIV testing when status is unknown * Severe illness resulting in unstable condition * Absolute contra-indication to any of sampling procedures required by the study (ie: acute severe asthma, pertussis syndrome etc.)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diagnoses disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor Eswatini Clinical Centre of Excellence (COE)
Mbabane, Eswatini
-
Centro de investigação de Saúde de Manhiça
Manhiça, Maputo Province, 1929, Mozambique
-
Makerere University
Kampala, Uganda
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New malaria test aims to catch hidden infections in pregnant women
- Can a Once-Daily HIV pill with food match Twice-Daily dosing during TB treatment?
- Can simple sputum and urine tests catch tuberculosis earlier?
- Can a common virus be turned into a TB vaccine? scientists test VIR-1778
- Fish oil meets TB drugs: can Omega-3 help clear infection faster?
- Can starting TB treatment immediately save lives in HIV sepsis?